Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
302
-
Total 13F shares, excl. options
-
93.3M
-
Shares change
-
+592K
-
Total reported value, excl. options
-
$5.02B
-
Value change
-
+$80M
-
Put/Call ratio
-
0.69
-
Number of buys
-
150
-
Number of sells
-
-135
-
Price
-
$53.83
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2022
389 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2022.
Guardant Health, Inc. - Common Stock (GH) has 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.3M shares
of 124M outstanding shares and own 75.34% of the company stock.
Largest 10 shareholders include FMR LLC (15.2M shares), VANGUARD GROUP INC (8.92M shares), Capital International Investors (6.15M shares), BlackRock Inc. (5.27M shares), MORGAN STANLEY (4.99M shares), VIKING GLOBAL INVESTORS LP (3.84M shares), Clearbridge Investments, LLC (3.11M shares), FRANKLIN RESOURCES INC (2.96M shares), Capital Research Global Investors (2.15M shares), and CREDIT SUISSE AG/ (1.81M shares).
This table shows the top 302 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.